pfizer biontech - Search News

News

Pfizer raises 2025 profit forecast

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday. CEO Albert Bourla also said the company has been in active discussions with members of the U.

Bloomberg on MSN · 9h

Pfizer Raises Profit View as Cost Cuts Offset Poor Sales Growth

Pfizer Inc. raised its profit forecast for the year with the drugmaker’s ongoing cost cuts helping to make up for a lack of sales growth.

CNBC on MSN · 10h

Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results

The results come as Pfizer and other drugmakers grapple with Trump's calls to lower U.S. drug prices and brace for his planned tariffs on pharmaceuticals.

4don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Zacks.com on MSN4h

Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth

PFE posts strong Q2 results with earnings up 30% and revenues up 10% year over year, fueled by rising oncology sales and cost ...

1don MSN

BioNTech's Q2 revenues double on higher COVID vaccine sales

FRANKFURT (Reuters) -German biotech firm BioNTech on Monday said that second-quarter revenues more than doubled to 261 ...

BioSpace1d

BioNTech Commits to Infectious Diseases Amid Questions Over Vaccine Demand

The company expects that the U.S. COVID-19 vaccination rate will be “maybe a couple of points lower” than the prior level of ...

The Manila Times on MSN3d

Pfizer and BioNTech lose UK court appeal over Covid-19 jab

Pfizer says it will appeal the Aug 1 ruling to Britain’s Supreme Court. Read more at straitstimes.com. Read more at ...

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...

BioSpace4d

Moderna Wins UK Patent Battle Against Pfizer and BioNTech

A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.

TheHealthSite on MSN15d

Pfizer-BioNTech's COVID-19 Vaccine: What Does A Thicker Cornea And Reduced Cell Density Mean?

BioNTech's COVID-19 vaccine on one's eye, which could lead an indivual to permanent vision loss. Read on... TheHealthSite.com ...

Earnings live: Palantir stock pops, Pfizer beats, Caterpillar warns of tariff impact

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results